During the mass mRNA injection campaign, brain tumors, colon and rectal cancers, small intestine cancer, and ovarian cancer all rose sharply among Americans under 50.
The official cancer numbers are in, and they’re alarming.
According to the National Cancer Institute’s latest SEER data release, cancer incidence rates among Americans under age 50 jumped 6.4% between 2021 and 2023 — with colon/rectal cancer (+19.4%), brain tumors (+19.5%), small intestine (+15.5%), ovarian (+12.8%), stomach (+7.3%), and breast cancer (+3.6%) all showing very alarming signals — right in the middle of the mass mRNA injection campaigns.
Here are the actual observed rates straight from the SEER explorer:
All cancers combined (age <50)
-
-
- 2021: 109.45 per 100,000
- 2023: 116.42 per 100,000
- <+6.4% increase in just two years
-
U.S. GOVERNMENT CANCER DATA JUST DROPPED
Overall cancers in those under 50 JUMPED 6.4% from 2021 to 2023 during mass mRNA uptake.
BRAIN TUMORS: +19.5%
COLON/RECTAL CANCER: +19.4%
SMALL INTESTINE CANCER: +15.5%
OVARIAN CANCER: +12.8%
STOMACH CANCER: +7.3%
BREAST CANCER: +3.6%https://t.co/bbwmul9Ph2 pic.twitter.com/rkWD62GLQK
— Nicolas Hulscher, MPH (@NicHulscher) April 24, 2026
